Skip to content
healthcare.dev

REZDIFFRA

NDC 82576-100, RESMETIROM, tablet, coated, from Madrigal Pharmaceuticals, Inc..

Product NDC
82576-100
Status
Listed
Labeler
Madrigal Pharmaceuticals, Inc.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217785
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82576-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RESMETIROM100 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]; Thyroid Hormone Receptor beta Agonist [EPC]; Thyroid Hormone Receptor beta Agonists [MoA]

Package NDCNDC-11Package
82576-100-308257601003030 TABLET, COATED in 1 BOTTLE (82576-100-30)
82576-100-908257601009090 TABLET, COATED in 1 BOTTLE (82576-100-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e67ea09f-a840-439c-86c8-f98585f978b2

Use it

Look up 82576-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82576-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82576-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.